When did Abivax (ABVX) last report earnings?

Abivax last reported on May 22, 2026, covering fiscal Q1 2026.

Did ABVX beat earnings estimates?

Yes. Abivax reported EPS of −$0.70 for Q1 2026 against a −$0.94 estimate — a 24.89% beat.

How much revenue did ABVX report last quarter?

Abivax reported $1.5M in revenue for Q1 2026, against a consensus estimate of $401,125.00.

Abivax (ABVX) earnings history

Most recent quarter

Fiscal period: Q1 2026
Period end: Mar 31, 2026
EPS actual: −$0.70
EPS estimate: −$0.94
EPS surprise: +24.89%
Revenue surprise: +277.30%
Revenue: $1.5M
Revenue estimate: $401,125.00
Reported: May 22, 2026
SEC filing: View filing

Earnings history

Period	Reported	EPS estimate	EPS actual	Surprise	Revenue	Filing
Q1 2026	May 22, 2026	−$0.94	−$0.70	+24.89%	$1.5M	SEC
Q4 2025	Mar 23, 2026	−$1.35	−$1.20	+11.02%	$515,064.00	SEC
Q3 2025	Dec 15, 2025	−$0.79	−$2.47	−214.27%	$2.4M	SEC
Q2 2025	Sep 8, 2025	−$0.93	−$0.97	−4.45%	$1.3M	SEC
Q1 2025	Jun 2, 2025	−$0.76	−$0.97	−28.31%	$1.2M	SEC

Quarterly revenue

Q1 2025

$1.2M

Q2 2025

$1.3M

Q3 2025

$2.4M

Q4 2025

$515,064.00

Q1 2026

$1.5M

Frequently asked questions

When did Abivax (ABVX) last report earnings?
Abivax last reported on May 22, 2026, covering fiscal Q1 2026.
Did ABVX beat earnings estimates?
Yes. Abivax reported EPS of −$0.70 for Q1 2026 against a −$0.94 estimate — a 24.89% beat.
How much revenue did ABVX report last quarter?
Abivax reported $1.5M in revenue for Q1 2026, against a consensus estimate of $401,125.00.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by